Off to a great start
In January, the stock stumbled as one analyst predicted that Apple might turn to Sony
The next month, OmniVision blew the roof off analyst targets in a stellar earnings report. "We feel very, very comfortable in the marketplace in whatever competitive landscape we come across," said sales VP Ray Cisneros. Once again, this stock looked like a terrific cross-platform play on the smartphone market.
The company beat expectations again in May and the stock hit an all-year high at $37 per share. I compared the stock to Intuitive Surgical, based on the robotic surgery expert's totally unassailable technology lead. "The Backside Illumination, or BSI, sensor chip structure is every bit the cash-cow selling point I expected it to be," I said.
Hold on to your hats, folks -- it's all downhill from here. Time to start eating crow.
There are ghosts, not gold, in them thar hills
When the supposed iPhone 4S finally showed up, Apple bragged about the "next-generation backside illumination sensor" with its increased sensitivity and short exposure times. Sure sounded like OmniVision!
When third-party experts tore the phones apart, they found the usual Cirrus Logic
With this much of the phone's guts built by the same old suppliers, why would OmniVision lose the camera slot? This ghostly X-ray image of the sensor chip came as a shock:
Image from Chipworks.
Yep, that's a Sony logo for sure. Though analysts insist that Apple probably dual-sourced this chip with a hearty helping of OmniVision models, IHS iSuppli and Chipworks have so far reported five Sony instances and no OmniVisions between them.
So the Apple of OmniVision's eye looks rotten to the core. Winning the secondary, front-facing camera spot isn't nearly as impressive or important because it's a much lower-end and cheaper part. The firm does provide camera sensors to other hot-selling smartphones, including the Motorola RAZR and Droid Bionic, but these things just don't sell in the massive volumes the iPhone does.
So here we are, denied an OmniVision-powered iPhone 4S and with share prices some 60% below the January level. The company is now in the habit of posting gloomy forecasts, though sometimes they're not quite pessimistic enough. Sony has apparently caught up in the BSI race and can deliver competitive chips at reasonable prices. OmniVision's next-generation BSI 2 technology is too new to make an impact just yet, though bulls hope that this evolution will keep the good times rolling a while longer.
2011 wasn't kind to OmniVision. I'm keeping my shares because they're priced for absolute disaster and no more growth, ever. Will 2012 be a different story? I believe it will and have real money backing that prediction, but only time will tell. Add OmniVision to your Foolish watchlist so you can follow this yarn as it happens.
OmniVision isn't the only great smartphone play for 2012, either -- here's three more ideas from Fool analysts.
Fool contributor Anders Bylund owns shares of OmniVision and Intuitive Surgical but holds no other position in any of the companies mentioned. The Motley Fool owns shares of Apple, Qualcomm, Cirrus Logic, and Texas Instruments. Motley Fool newsletter services have recommended buying shares of Apple and Intuitive Surgical, as well as creating a bull call spread position in Apple. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinion, but we all believe that considering a diverse range of insights makes us better investors. Check out Anders' holdings and bio, or follow him on Twitter and Google+. We have a disclosure policy.